PTTG: an important target gene for ovarian cancer therapy

  • Panguluri S
  • Yeakel C
  • Kakar S
N/ACitations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pituitary tumor transforming gene (PTTG), also known as securin is an important gene involved in many biological functions including inhibition of sister chromatid separation, DNA repair, organ development, and expression and secretion of angiogenic and metastatic factors. Proliferating cancer cells and most tumors express high levels of PTTG. Overexpression of PTTG in vitro induces cellular transformation and development of tumors in nude mice. The PTTG expression levels have been correlated with tumor progression, invasion, and metastasis. Recent studies show that down regulation of PTTG in tumor cell lines and tumors in vivo results in suppression of tumor growth, suggesting its important role in tumorigenesis. In this review, we focus on PTTG structure, sub-cellular distribution, cellular functions, and role in tumor progression with suggestions on possible exploration of this gene for cancer therapy.

Cite

CITATION STYLE

APA

Panguluri, S. K., Yeakel, C., & Kakar, S. S. (2008). PTTG: an important target gene for ovarian cancer therapy. Journal of Ovarian Research, 1(1). https://doi.org/10.1186/1757-2215-1-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free